GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

Peter Humaidan, H.E. Bredkjær, Leif Bungum et al. · Human Reproduction · 2005 · 494 citations

Veterinary Medicine, Endocrinology, Gynecology +14

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study

Lawrence Engmann, Andrea DiLuigi, David Schmidt et al. · Fertility and Sterility · 2007 · 430 citations

Medicine, Endocrinology, Gynecology +17

Endocrine Profiles after Triggering of Final Oocyte Maturation with GnRH Agonist after Cotreatment with the GnRH Antagonist Ganirelix during Ovarian Hyperstimulation for<i>in Vitro</i>Fertilization

Bart C.J.M. Fauser, Diederick De Jong, F. Olivennes et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 333 citations

Medicine, Endocrinology, Gynecology +17

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

Efstratios M. Κolibianakis, A. Schultze-Mosgau, Andreas Schröer et al. · Human Reproduction · 2005 · 324 citations · Full text

Veterinary Medicine, Endocrinology, Gynecology +15

Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist

Joseph Itskovitz, Rafael Boldes, Jacob Levron et al. · Fertility and Sterility · 1991 · 312 citations

Medicine, Endocrinology, Gynecology +16